quote:

---

Ok...I think you guys have all seen Etrade's "CMKM DIAMONDS INC TENDER OFFER AMEX" ? Right? Right.

Okay, many people called etrade (over 3 credible people) and etrade stated that cusip#125809996 has no current name or ticker but has registered to be on the AMEX already. It is just waiting on the parent company, CMKM, to accept the tender offer. Etrade said that cusip#125809996 will recieve its identity by midnight tonite and will be posted to Etrade accounts tomorrow morining.

Now, on monday cmkx will tender offer our cusip #125809996 shares to the big boy investors that have been waiting on the sidelines for the last few months. Once these big boys buy ours #125xxx (no name yet) shares, then they will IPO it. We will recieve the cash tender offer into our accounts and the company will release news to give valuation to #125xxx. Then it will take off and we will have cash into our accounts.

This is awesome because the new public company #125xxx will have no nss problems since it emerged from a private company.

Later, CMKX will issue another #125xxx dividend to us. Perhaps, it will be the remainder of our current #125xxx dividend. It is speculated that we have only been paid 1/2 of our dividend.

By that time, we should have plenty of cash and stocks that are actually worth something.

Cmkx will then continue with operation dividends and attack the shorts. I believe that the cmkx pps will never really rise as we will now focus on #125xxx and our several dividend companies.

---

I disagree with his last statement. CMKX will retain mineral claims in Canada and work them. Since this will take a year plus it will give time to correct share problems.

It will eventually be a good company. A long term play.

I do believe those who received the IPO shares will do well short term.

quote:

---

Add up all the value of the dividends and they will be equal to or greater than your purchase.
UCAD
CIM
GEMM

and whatever else. UCAD is worth 4100 dollars to me and is more than I paid for the shares.

---

Now that truly is an example of seeing the world through rose colored glasses. Here's how I see it:

UCAD: worthless (as of now)
CIM: worthless

That's all we've received so far, total value? $0.00

I agree with you, but it is possible UCAD will go up in price and be worth much more than current.

In my opinion, when you have a spinoff it is never easy to satisfy everyone, but I believe it would meet legal obligations to all except those who bought after the dividends.

My theory is dangerous because it could create an impression that CMKX is worthless now and no one would buy.

If my thinking is wrong and they are going to play CMKX then I hurt my own chances.

It is true the divvy's are worthless now, but I doubt Roger Glenn would neglect his responsibilities so openly if he was simply scamming shareholders. There will always be unhappy people, but the idea he could do it so openly is absurd to me.

quote:

---

Originally posted by bill1352:
reguarding the few CIM posts...i too have had in the back of my mind that something was going on with this company as in UC transfering assets into it. the dividend had to be split in half as the a/s of cmkx is 800 billion and the split worked out to twice that. i wouldn't be too suprised if when & if CIM hits the market its pps has real value but remember this dividend is restricted too so even if it goes public it can't be sold. i also agree this is the cover UC's azz play. i think roger took a good look at everything & told UC either come up with something good or learn how to shower without ever dropping the soap

---

quote:

---

i think roger took a good look at everything & told UC either come up with something good or learn how to shower without ever dropping the soap

---

quote:

---

Originally posted by Upside:
Tony,
From the other thread we both frequent I know you're a bit of a gambling man so help me out with something would you? What kind of odds should I lay down that the convoluted theory in Raiders copied post never comes to pass? I'm thinking of going pretty high if someone wagers on it happening by Monday then lowering the odds, allowing people to pick week long blocks over the course of the next 5 years or so. What do you think? One way or the other, this stock WILL make me rich!

---

Just looking at the logistics of it, then I think it is possible. One of the uses is restricted 144 stock and using it to IPO.

It comes with a contractual promise to make them tradeable as soon as possible.

quote:

---

PIPE transactions are privately issued equity or equity-linked securities that are sold to accredited investors under Regulation D by public companies. PIPE issuers range in size from small OTC Bulletin Board companies to large-cap NYSE-traded companies. Transaction sizes have ranged from under $1 million to over $200 million. In 2003, approximately 1,400 PIPE transactions were completed for total proceeds of approximately $18 billion. This activity is up from approximately 800 transactions for proceeds of approximately $14 billion in 2002.

PIPE investors have shown interest across a broad range of industries. In 2003, healthcare and technology/ communications issuers accounted for approximately 42% of proceeds raised, down from approximately 65% in 1998. Companies in many other industries accessed the PIPE market in 2003, including issuers in the mining, chemicals, energy, utilities, consumer, financial, REIT and industrial sectors.

Within the spectrum of equity alternatives for a publicly traded company, a PIPE transaction generally best fits companies with a market capitalization under $400 million that seek an equity infusion of less than $75 million. Traditional public equity alternatives include add-on equity offerings (“secondary” or follow-on offerings) and 144A convertible securities. These transactions are typically underwritten and require extensive institutional and/or retail distribution networks. Due to the need for liquidity in the secondary trading market for these types of securities, as well as the overhead requirement on the part of the underwriter, the minimum transaction size is typically $65 million to $100 million to achieve optimal execution for traditional public offerings.

While a PIPE transaction is marketed to a limited number of investors over a short period of time, a traditional public transaction may require a broader marketing process and, in the case of an add-on offering, the filing of a registration statement with the SEC prior to pricing. This filing process tends to create an overhang in the market, resulting in an “announcement effect” on the issuer’s stock. This announcement effect has been studied, and most practitioners use a proxy of a 15% decline in the stock price prior to pricing. For companies that are able to access traditional public alternatives for larger amounts (typically above $75 million), pricing at the close of the transaction may be more issuer-friendly than a PIPE transaction due to broader marketing and the lack of any liquidity discount associated with receiving unregistered securities. However, careful review of the entire process must be conducted to determine the full array of strengths and weaknesses associated with each alternative.

ISSUER CONSIDERATIONS

Following are the benefits a potential issuer may consider when evaluating a PIPE transaction:

Does not require SEC registration prior to offering
Allows for a more flexible transaction size than traditional public alternatives
Improves balance sheet strength and financial flexibility
Offers greater confidentiality and eliminates typical price declines on filing of traditional public offering (“announcement effect”)
Requires minimal preparation before launch
Increases issuer’s trading liquidity levels and diversifies shareholder base
Allows for a targeted marketing process, reducing management’s time contribution
PIPE TRANSACTION TYPES

PIPE transactions may be issued in a variety of forms, including registered common stock (“registered directs”), unregistered common stock, convertible preferred stock, convertible debt and equity credit lines (“ECLs”).

Registered Direct Common Stock Common stock issued under an existing and effective registration statement. Essentially a traditional add-on offering marketed to, and negotiated with, a select investor universe vs. broad marketing from an institutional and retail sales force. This security offers the investor the benefits of receiving registered shares. Issuers have the benefit of mitigating a liquidity discount and broadening the investor base.
Common Stock Common stock issued as a private placement under Regulation D with an agreement to register the shares as soon as possible after the transaction closes. Provides investors with the ability to build a position in a security and enables the issuer to quickly and quietly access the equity market. A liquidity discount is typically incorporated into the pricing due to the fact that the investor is unable to trade the shares until they are registered.
Convertible Preferred or Convertible Debt Equity-linked security structured as preferred stock or subordinated debt. The security is issued as a private placement with an agreement to register the underlying shares as soon as possible after the transaction closes. Provides an investor with a senior position relative to the common shareholders as well as current income in the form of a dividend or coupon. Provides an issuer with broad flexibility with regard to structure and the ability to issue stock at a premium to a straight common stock alternative. Issuers should understand that convertible transactions tend to cause “overhang” in the market, i.e., the downward pressure on stock prices due to the existence of a sizeable block of securities that will be released into the market. Depending on the structure, consideration should also be given to rating agency treatment and senior debt covenants, if applicable.
Equity Credit Line A contractual agreement between an issuer and investor that enables the investor to purchase a formula-based quantity of stock at set intervals of time, typically monthly, at future stock prices. Formulas tend to be based on trading liquidity. An effective registration statement must be maintained in order for drawdowns to be completed.

HISTORY OF THE PIPE MARKET

While PIPEs have been issued for over 10 years, the transaction category truly emerged as a source of financing for companies in the mid-1990s. During this period, PIPE deals were primarily opportunistic financings for small and/or distressed high-growth companies, typically structured with floating conversion prices known as “death spiral” transactions. This negative taint was soon vetted in the press and in the legal arena, providing insight and education to issuers and advisors. This attention impacted the investors in PIPE securities to structure transactions with more issuer-friendly terms, which in turn attracted more companies to entertain and issue PIPE securities, resulting in the higher volumes of issuers accessing the market in recent years.

As a result of increased size and diversification, the PIPE market has been institutionalized over the past three years. Industry newsletters, conferences and databases track the market closely, providing a level of visibility into market participants, structures and process. Several legal and financial advisors have entered the business. Application of proceeds has also broadened from strictly smaller amounts of growth capital to acquisition financing, de-leveraging, working capital and secondary sales.

The relevance of the public equity add-on market is often discussed in the context of the growth potential of the PIPE market. While public equity add-ons have had mixed performance in recent years, this market continues to be significantly larger than the PIPE market. There were over 400 add-on transactions in 2003 with proceeds of approximately $60 billion. Comparing this to the 2003 PIPE market proceeds of approximately $18 billion indicates that the PIPE market will not replace the add-on market. Instead, the PIPE market should support a targeted market of small- and micro-cap companies that do not appeal to the traditional public add-on market investor, as well as mid-cap companies that prefer faster execution and confidentiality.

PIPE MARKET: HISTORICAL SIZE AND VOLUME
INCLUDES REGISTERED DIRECT COMMON STOCK,
COMMON STOCK AND CONVERTIBLE SECURITIES

© 2004 Houlihan Lokey Howard & Zukin. All rights reserved.
Unauthorized duplication is prohibited.

Houlihan Lokey Websites

Houlihan Lokey Websites
Corporate Site
Aerospace•Defense•Government Basic Industrial Group
Consumer, Food & Retail
Media, Sports & Entertainment
Engineering & Construction
Financial Institutions Group
Healthcare
Real Estate•Lodging•
Homebuilding
Technology
Recruiting
Private Equity
Business Forum
Feedback | Recruiting Terms of Service | Privacy Policy | Disclaimer | Business Continuity
Questions & Feedback [Hide]

For More information
In the United States, you can reach your nearest Houlihan Lokey Howard & Zukin office by calling us toll free at 800.788.5300.

In Europe including the United Kingdom, please call us at
+44 (0)20.7839.3355.

For technical questions or feedback regarding our web site, write to webdev@hlhz.com .

Site Map

---

quote:

---

The big theory now is a PIPE transaction.

---

quote:

---

In short, "outside the box" to CMKX would be to do what most companies do as a normal course of business. [/B]

---

very good point and probably the best post of the day.

i agree 100% with you in this one.

quote:

---

Could use transaction type or date or UC goes to jail.

---

quote:

---

Originally posted by Upside:
originally posted by RaiderJR:
I've got a hunch though that UC has a "get out of jail free" card.

---

quote:

---

Upside go look at the nvcm thread. I posted last night.I had it typed in this morning and passed.Another great move.Sometimes you just gotta laugh or in this case cry.LOL ouch

---

1. If OS = 40 billion = our dividend

2. Offer increases as value increases.

zinc claim
uranium claim
diamond claims
gold mine or mines
diamond mine in south america

3.

300 million/40 bill = .0075

1 bill/40 billion = .025

3 bill/40 billion = .075

10 bill/40 billion = .25

Depends upon true O/S and the value given. Who really knows.

Could be from 100.00 to 150,000.00

Since our dividend could be 1.6 trillion based, or half of 779 billion which would be

20 billion to start the ipo, then all figures could be divided by 20 billion.

300 mil/20 bil = .015

1 bill/20 bil = .05

3 bil/20 bil = .15

10 bil/20 bil = .5

quote:

---

Originally posted by JEAL:
TruthTeller -

This is what led me to the other statement - I honestly believe that there will be "something" within the next week or two. Or some announcement made during this time. - as every shareholder needs to have the same opportunity for hearing news at prime time.

---

quote:

---

Originally posted by Upside:
originally posted by tigertony:
Yep, we all missed that one. You know sitting at work and typing garbage all day on a CMKX thread doesn't bode well for my finding other stocks. Not the smartest career move on my part either.

---

quote:

---

Originally posted by Az...Cats:
[QUOTE]Originally posted by tradingpennys:
[b]I sold a million at .0002 last week and then today I sold another million at .0002. Today's sell took 4 1/2 hrs. to finally go through.

---

UNDERGROUND STOREHOUSES ARE LOCATED FROM SPACE

8/7/02

Industry - Engineering Newspaper (Moscow)

Scientists at the Moscow-based Earth Geoinformation Analysis Research Center have developed a unique technology for detecting mineral resource reserves based on remote terrestrial surface sensing from space.

The essence of this new technique, which has already made it possible to find water in the Sahara desert, consists of the fact that specialists receive highly accurate multidimensional photographs of the Earth from space, then process them using computer programs they have developed, and - without performing geological work in an area that is being studied - provide a precise prediction of the resources occurring under the earth.

The structurometric analysis technique is based on the fact that all underground resources manifest themselves on the surface in one way or another: the Earth's core emits energy that, in proceeding to the surface, is refracted as a function of the rocks through which it passes. This creates a unique trace on the surface, the nature of which is dependent upon what is located under the earth. Russian specialists have learned to "read" this trace. Or, in other words, to identify regularities and to present the traces detected in the form of accurate three-dimensional images of the resources occurring under the earth.

Producing firms have been trying for some time to use space land surveys to generate predictions of raw materials occurring under the earth. However, all the technologies employed to date have produced a low level of accuracy.

The uniqueness of the technology created by the coworkers of the Earth Geoinformation Analysis Research Center consists of the fact that it is made up of dozens of unrelated computer algorithms. In studying space survey data, these algorithms apparently crosscheck one another, ultimately producing an extremely precise prediction.

The structurometric analysis technique, on which a group of Russian scientists headed by academician Vladimir Zhukov worked for more than 20 years, makes it possible to identify and quite accurately describe mineral resource deposits within areas where it was previously thought they did not exist. Here, the cost of the prediction work is an order lower than that of the traditional geological exploration techniques currently in use.

This Russian technology also takes on greater urgency in light of the global problem of hydrocarbon raw material reserves on the planet. The center's director, Valeriy Tutykhin believes that, "Our technology makes it possible to quite accurately estimate oil-and-gas reserves over extremely large areas in any country". He says, "The structurometric analysis technique is already being used by specialists when performing prediction work for a number or Russian companies, as well as oil-, diamond-, and gold-producing firms abroad".

In particular, at the request of the Mauritanian government, specialists from the center where this technology was developed, in March of this year, performed remote terrestrial surface sensing from space within this North African republic in order to look for underground fresh water. They provided a prediction of its presence in the Varan region not far from the city of Atar.

In July, while drilling at the site pinpointed by the center specialists, flowing water was found at a depth of approximately 30 meters. "The result fully satisfied the client. However, we suggested to our Mauritanian colleagues that they continue their drilling work, since our predictions indicated a considerably large water flow under a hard volcanic rock "cap" at a depth on the order of 250 meters," V. Tutykhin said.

The Russian specialists were successful in convincing the project managers not to halt the work and to continue drilling to the 250-meter mark, despite the fact that penetrating the hard rock broke three diamond drill bits.

The practical drilling results stunned the Mauritanians. An underground flow of colossal proportions was discovered beneath a volcanic rock stratum. The initial well flow rate was 32,000 liters an hour. The water reserves found are not only capable of meeting the needs of Atar's population, but are also of vital strategic importance to the country as a whole, the bulk of which is covered by the sandy and rocky deserts of the Western Sahara. As one of the project participants noted, "this fountain in the Sahara is a present-day wonder of the world".

In the opinion of the Russian scientists, the discovery of this water under hard volcanic rock can tentatively be explained by the fact that magmatic lava collapsed the bed of a large river in prehistoric times, the course of which subsequently went underground.

Using this same new technology, gold ore reserves were detected in South Korea in April.

UNDERGROUND STOREHOUSES ARE LOCATED FROM SPACE. Industry - Engineering Newspaper (Moscow), 7/8/02, 024, p. 2.
http://www.research-centre.org/news4.php

Does this fit CMKX?

quote:

---

--------------------------------------------------------------------------------

SAN FRANCISCO, June 8, 2000 BACK TO NEWSLETTERS LIST

--------------------------------------------------------------------------------

SHAREHOLDER UPDATE / AGM 2000
The following is a report on the activities at the Annual Meeting of Shareholders held May 31, 2000 in Sausalito, California.

Opening Comments

Medizone's Chief Operating Officer, Dr. Jill Marshall, opened the presentation with a discussion on shareholder relation topics and commonly asked questions. Jill stated that when shareholders want to make changes, i.e. address changes and stock transferring, they need to notify American Stock Transfer and Trust in writing. The address is: 40 Wall Street. New York, NY 10005, phone number: 212-936-5100. For legend removal, shareholders need to call Jill directly for instructions. Jill also talked about Medizone's web site and how anyone interested could view any of the SEC filings, Management Profiles, Updates, Press Release Archives and outstanding science articles by Dr. Sunnen, by clicking on the applicable buttons located on the homepage.

Official Business of the Meeting

The official meeting was then opened by Chairman and CEO, Edwin Marshall. The official business consisted of electing 3 directors; Edwin Marshall, Dr. Gerard Sunnen and Richard Solomon and approval of H&J Associates (formerly Jones, Jensen & Company) as the auditors for the next year. The final results of the proxy vote are now reported as follows: FOR ALL DIRECTORS AND APPOINTMENT OF JONES JENSEN, 92,520,651. AGAINST, 150,150. ABSTAIN 850,692. The official business of the meeting was then closed.

Discussion Period

Following the close of the Annual Meeting, the shareholders and others in attendance were invited to remain for discussion of current developments at the Company. The first item of discussion was the May 23 press release , which can be viewed in the Press Release Archives section of this web site. That press release on a Funding Program, Scientific Progress and Future Intentions was released to 50 countries via PR Newswire in San Francisco. The Company anticipated a favorable market reaction following this release. The initial market response indicated this would be the case as the price increased 70% over the previous day's close on heavy volume during the first few hours of trading the morning of the release. Then, as has happened in the past with our stock, the Market Makers appeared to "cap" the stock. In other words, the price of the stock appeared to be held at a limited level that does not allow the stock to move to a natural level based on the free market rule of supply and demand. In the days following the shareholders meeting, the stock was brought down again, in the opinion of the Company, artificially.

A discussion then ensued as to the perceived lack of enforcement of existing rules by the SEC and NASD Regulation in regards to Market Makers on the OTC:BB and the requirement for them to make a "fair market". Unlike the National NASDAQ markets or the New York Stock Exchange, market makers on the OTC:BB are not required to report a short position in securities traded over the counter. The Company believes this creates an environment that invites the violation of fair market standards that market makers are legally required to provide.

The Company has come to the conclusion, based on comparing the daily report it receives from American Stock Transfer and Trust Co., Medizone's transfer agent, and viewing the Share Volume Report, as well as other information that is available, that the buy/sell ratio in Medizone stock is consistently tilted in the buy direction. In other words, over time there has not been a balanced buy/sell ratio in Medizone stock. Predominantly, Medizone shareholders tend to be long term, patient shareholders interested in the advancement of the science as much as turning a profit. Thus, based on the information available to it, the Company has come to the conclusion that there is a long term accumulated short position in the market maker community. This creates a pressure that is not only detrimental to the short term appreciation of stock value, but encouraging of illegal activities such as collusion and manipulation for those, who on the one hand have a legal obligation to provide a fair market for the Company's stock, and on the other hand are so short the stock that it would be financially detrimental to allow the stock to rise to a fair market value based on the law of supply and demand. This last assumption is based on the belief that some of these short sellers who may nominally hold themselves out as market makers of our stock, could only cover their naked short positions by spending significant sums of money buying stock on the open market in order to cover their short interests. The financial incentive for those short sellers is to protect their position. In other words, do every thing possible to keep a lid on the price.

The Company believes the best way to address this issue is to view it as a short term problem that will be overcome by further development of our science, including; the filing of additional new patents, the publishing of successful double blind studies in major countries by internationally renowned virologists, hepatologists and infectious disease experts. Continuing and additional funding and the construction of a production facility intended to be on line by the end of the 3rd quarter of 2001 with the start of revenue production currently estimated for the 4th quarter of 2001. These activities, along with a staff increase of very highly qualified individuals, some of international renown joining the Medizone team, will present a force that will be impossible to hold down, regardless of possible collusion, market manipulation and foul intent for reasons of self preservation and financial greed by a few who operate in a secretive environment that the Company views as being in need of rule changes as well as sticker enforcement of existing regulations.

In this regard, the Company's law firm, Durham, Jones & Pinegar has prepared a letter to be presented to the United States Securities and Exchange Commission, with copies to NASD Regulation and certain elected representatives in Washington who chair oversight committees of those agencies. That letter as well as a letter from the Company on the same subject was filed on June 8, 2000. Both letters may be viewed on the Company's web site under Shareholder Communication. Please do not think we are so naive to think we might actually bring about regulatory change. We view that as a long shot at best. However, we are genuinely concerned for the liquidity of some of our shareholders should certain market makers be forced into a situation in which they find it difficult to cover their short positions. In other words, if it became difficult to provide stock to shareholders with street accounts. As a Company, we are simply going to put the appropriate authorities on notice of what our concerns are, the SEC is reviewing this issue and we hope to have our voice heard. It is up to those authorities to take action to correct the situation, or to ignore it. To protect your position as a shareholder we strongly urge all of you to write to your broker and insist that the broker holding your stock do two things. First, register the share certificate in your name. Second, the broker should agree in writing not to use the certificate as collateral for short selling. To authorize your broker to act as your agent you must give him a power of attorney for buy and sell orders. If you do these things the broker/client relationship will not be broken, but you will prevent your stock from being used against your best interests.

Please note that this Company is not the only Bulletin Board listed company that believes it has this problem. Since posting the letter of May 26 relative to this issue on our web site, I have been contacted by the executives of a number of companies who have had similar problems. It is pretty obvious when you are on the "inside" what is going on when you release very positive news, the shareholder¹s response to the news is positive and then the market goes down. There is no explanation except intentional manipulation. When a Company¹s buy/sell ratio on a given day is weighted 90% toward the buy side, at least in the retail market, how would you otherwise explain a decline in price on that same day?

Let me close this subject by saying the Company's intention is to enter into the public record its view of this on-going problem in the market place and offer some possible solutions. We believe it is imperative for the shareholders of all publicly traded companies to be equally protected under the law. That is clearly not the case today. Beyond that, it is not our job to change the market place. It is our job to build this company, prove its science and bring about a revolutionarily change in the world of medicine relative to viral illness and other issues the company believes it has answers for in a world of great need. That is our job, and that is what we intend to focus on.

The presentation then moved into the field of research. The work of recently retired board member Dr. William Hitt was discussed. As reported in the May 23rd press release, Dr. Hitt is being very successful with his work in hepatitis C. He has additionally worked with a few HIV and herpes patients with encouraging results, but the number of patients treated is very low and the Company has chosen not to report these results for lack of depth of information. The hepatitis C results of 5 log viral load reductions and other significant signs of patient well being reported in the press release of May 23rd are based on 6 month post treatment follow up results as well as immediate patient improvement. In all, Dr. Hitt has treated over 30 patients with hepatitis C as of this date. The information the Company has obtained from this work, while done without a blind control in "anecdotal circumstances", is nonetheless less very useful. We know our process works! The next step, as previously reported on May 23rd, will be to prove this in independent studies done in other countries.

Dr. Sunnen discussed the viral program at length and also the future intentions of the Company to pursue an agenda for the external applications of ozone to treat pathogenic conditions such as burns, slowly healing wounds, ulcerations, etc. To understand the viral inactivation program better, shareholders are encouraged to refer to the "Virology Primer with special reference to ozone" in the science section of this web site. The external program will not be started until the viral inactivation program is very well established, nearing the end of the research stage and production is ready to start. This current Company position is based on limited human resources and subject to change.

The Company then did a presentation on its patent development program. Morgan & Finnegan, our New York patent firm, along with a high volume of quality work by Dr. Sunnen, has resulted in a serious strengthening of the Company¹s patent situation internationally. Along with the granting of a patent for the Company¹s previous application on externals, a new application was filed on May 24th titled, METHOD AND APPLICATION FOR OZONE DECONTAMINATION OF BIOLOGICAL LIQUID, Our ref. No.; 1299-4015.

Assuming this patent is granted, as anticipated, the Company will then have 4 existing patents, all of which interlock and relate to each other. The near term filing of an additional patent application relative to the Company¹s blood / serum interface is anticipated Though narrow in scope, that patent application will deal with the cartridge that is the Company¹s "disposable", a major revenue producing tool. That filing will give the Company 5 patents (counting the two in the application stage).

The scope of the Company's international patent coverage was then emphasized by providing a global list of regions covered.

---

Consider this: in 2003 and 2004, shares in CMKM traded between 0.002 and 0.0001 cents. At 0.0001 cents per share, a million shares cost you $100. If you were lucky enough to catch a ride when the stock moved to 0.005 cents, which it did on occasion, and if there were enough buyers to get you out of your position, you would make a cool $4,900 profit.

However, if you were on the wrong side of the trade and bought at 0.005 cents, you would see your $100 dwindle to just $2 when the stock dropped back down to 0.0001 cents. And if you had a $20,000 position at 0.0001 cents you would have to sell 200 million shares to get out. In the sub-penny abyss, a few thousand dollars of buying or selling can significantly sway share values.